Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 7/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | TSPO | P30536 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15076071 | 0.84 | CETP (0.41) | CETPMAOBHPGDPPARGPPARA | |
| SCHEMBL15059092 | 0.83 | RIPK1 (0.40) | CETPMAOBTSPOHPGDPPARG | |
| SCHEMBL15546762 | 0.72 | POLB (0.49) | PPARGPPARAMRGPRX4 | |
| SCHEMBL15057124 | 0.72 | HPGD (0.45) | CETPMAOBHPGDPPARGPPARA | |
| SCHEMBL23519098 | 0.70 | PPARG (0.45) | HPGDPPARGPPARAMRGPRX4 | |
| SCHEMBL8209276 | 0.70 | MEN1 (0.61) | MAOB | |
| SCHEMBL15545838 | 0.69 | KCNN4 (0.50) | MAOBHPGDPPARGPPARA | |
| SCHEMBL16144539 | 0.69 | MAOB (0.42) | CETPMAOBPPARGPPARAMRGPRX4 | |
| SCHEMBL15076073 | 0.69 | GAA (0.47) | — | |
| SCHEMBL29435934 | 0.69 | GPR3 (0.50) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013092850-A1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |